Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research and development | 8.9 | 7.4 | 3.7 |
| General and administrative | 4.0 | 2.4 | 2.1 |
| EBIT | -12.8 | -9.8 | -5.7 |
| Pre-tax income | -12.6 | -9.7 | -5.8 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | |
| Net income | -12.6 | -9.7 | -5.8 |
| |
| Diluted EPS | ($0.63) | ($1.01) | ($0.65) |
| Shares outstanding (diluted) | 20.0 | 9.6 | 8.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|